Australian Broker Call *Extra* Edition – May 22, 2025

This story features ANZ GROUP HOLDINGS LIMITED, and other companies. For more info SHARE ANALYSIS: ANZ

The company is included in ASX20, ASX50, ASX100, ASX200, ASX300 and ALL-ORDS

An additional news report on the recommendation, valuation, forecast and opinion changes and updates for ASX-listed equities.

In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Australian Broker Call *Extra* Edition, featuring additional sources of research and insights on ASX-listed stocks, also enlarging the number of stocks that make up the FNArena universe.

One key difference is the *Extra* Edition will not be updated daily, but merely “regularly” depending on availability of suitable quality content. As such, the *Extra* Edition tries to build a bridge between daily updates via the Australian Broker Call Report and ad hoc news stories, that are not always timely for investors hungry for the next information update.

Investors using the *Extra* Edition as a source of input for their own share market research should thus take into account that information after publication may not be up to date, or yet awaiting another update by FNArena’s team of journalists.

Similar to The Australian Broker Call Report, this *Extra* Edition includes concise but limited reviews of research recently published by Stockbrokers and other experts, which should be considered as information concerning likely market behaviour rather than advice on the securities mentioned. Do not act on the contents of this Report without first reading the important information included at the end of this Report.

The Australian Broker Call *Extra* Edition is a summary that has been prepared independently of the sources identified. Readers will check the full text of the recommendations and consult a Licenced Advisor before making any investment decision.

The copyright of this Report is owned by the publisher. Readers will not copy, forward or disseminate this Report to any other person. For more vital information about the sources included, see the bottom of this Report.

COMPANIES DISCUSSED IN THIS ISSUE

Click on a symbol for fast access.
The number next to the symbol represents the number of brokers covering it for this report -(if more than 1)

ANZ   CSL   CXO   D2O   GTK (4)   LIN   MM8   NHC   RHC  

ANZ    ANZ GROUP HOLDINGS LIMITED

Banks – Overnight Price: $28.85

Jarden rates ((ANZ)) as Overweight (2) –

Jarden notes ANZ Bank’s new CEO Nuno Matos articulated two key priorities in his first week; accelerated pace of delivery and accountability, and uplift in risk management approach.

The broker concurs but also wonders if Matos would pursue goals far greater than an IT repair job and a bank migration.

Additionally, the broker believes Matos should aim to emulate CommBank’s ((CBA)) consistency, reliability and predictability approach.

Overweight. Target unchanged at $30.

This report was published on May 16, 2025.

Target price is $30.00 Current Price is $28.85 Difference: $1.15
If ANZ meets the Jarden target it will return approximately 4% (excluding dividends, fees and charges).
Current consensus price target is $27.25, suggesting downside of -5.5%(ex-dividends)
The company’s fiscal year ends in September.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 166.00 cents and EPS of 227.80 cents.
At the last closing share price the estimated dividend yield is 5.75%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 12.66.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 227.7, implying annual growth of 4.5%.
Current consensus DPS estimate is 164.0, implying a prospective dividend yield of 5.7%.
Current consensus EPS estimate suggests the PER is 12.7.

Forecast for FY26:

Jarden forecasts a full year FY26 dividend of 166.00 cents and EPS of 232.30 cents.
At the last closing share price the estimated dividend yield is 5.75%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 12.42.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 221.2, implying annual growth of -2.9%.
Current consensus DPS estimate is 162.8, implying a prospective dividend yield of 5.6%.
Current consensus EPS estimate suggests the PER is 13.0.

Market Sentiment: 0.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

CSL    CSL LIMITED

Pharmaceuticals & Biotech/Lifesciences – Overnight Price: $245.21

Jarden rates ((CSL)) as Overweight (2) –

Jarden’s Overweight rating on CSL is largely based on expectations of a recovery in gross margin at its Behring division, and a majority of that is linked to donor fees.

The broker recently surveyed the company’s sites for donor fee trends, and discovered a -10.9% reduction for new donors and -8.9% cut for return donors. For context, donor fees were raised during covid to boost collections.

The analyst expects gross margin improvements of 150bps in 2H26 and 115bps in 1H27 from fee reductions identified, and has factored in margin improvements from other sources.

All in all, the broker is now more confident of its forecast for 220bps margin improvement in 2H26 and 280bps in 1H27.

Overweight. Target rises to $317.61 from $314.37.

This report was published on May 18, 2025.

Target price is $317.61 Current Price is $245.21 Difference: $72.4
If CSL meets the Jarden target it will return approximately 30% (excluding dividends, fees and charges).
Current consensus price target is $327.51, suggesting upside of 33.6%(ex-dividends)
The company’s fiscal year ends in June.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 403.39 cents and EPS of 926.25 cents.
At the last closing share price the estimated dividend yield is 1.65%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 26.47.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 1011.4, implying annual growth of N/A.
Current consensus DPS estimate is 463.0, implying a prospective dividend yield of 1.9%.
Current consensus EPS estimate suggests the PER is 24.2.

Forecast for FY26:

Jarden forecasts a full year FY26 dividend of 443.57 cents and EPS of 996.61 cents.
At the last closing share price the estimated dividend yield is 1.81%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 24.60.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 1162.4, implying annual growth of 14.9%.
Current consensus DPS estimate is 527.1, implying a prospective dividend yield of 2.1%.
Current consensus EPS estimate suggests the PER is 21.1.

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

CXO    CORE LITHIUM LIMITED

New Battery Elements – Overnight Price: $0.09

Petra Capital rates ((CXO)) as Buy (1) –

Petra Capital highlights the restart plan for Core Lithium’s Finniss lithium mine is a positive development, with the study showing lower operating costs, larger capacity and doubling of mine life.

But it also requires capex funding, and the broker has assumed -$160m in equity raising. The equity portion could be lower if the company pursues non-dilutive options like project sell-down, prepayments or debt.

The broker has factored in equity dilution and mine restart study numbers into the forecasts.

Buy. Target price 14c.

This report was published on May 19, 2025.

Target price is $0.14 Current Price is $0.09 Difference: $0.05
If CXO meets the Petra Capital target it will return approximately 56% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.

Forecast for FY25:

Petra Capital forecasts a full year FY25 dividend of 0.00 cents and EPS of minus 1.00 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 9.00.

Forecast for FY26:

Petra Capital forecasts a full year FY26 dividend of 0.00 cents and EPS of minus 1.10 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 8.18.

Market Sentiment: 0.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

D2O    DUXTON WATER LIMITED

Agriculture – Overnight Price: $1.53

Petra Capital rates ((D2O)) as Buy (1) –

Petra Capital acknowledges its previous concerns on Duxton Water no longer exist, with weather-related headwinds turning into tailwinds, the company is now debt-free, and there’s an opportunity to internalise management.

The broker notes earnings and cash flow are likely to improve significantly as the climate pattern moves from La Ninas into a drier period.

The analyst believes the recent share price rally doesn’t fully capture the positives.

Buy. Target retained at $2.10.

This report was published on May 19, 2025.

Target price is $2.10 Current Price is $1.53 Difference: $0.57
If D2O meets the Petra Capital target it will return approximately 37% (excluding dividends, fees and charges).
The company’s fiscal year ends in December.

Forecast for FY25:

Petra Capital forecasts a full year FY25 dividend of 7.40 cents and EPS of 18.00 cents.
At the last closing share price the estimated dividend yield is 4.84%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 8.50.

Forecast for FY26:

Petra Capital forecasts a full year FY26 dividend of 7.70 cents and EPS of 10.50 cents.
At the last closing share price the estimated dividend yield is 5.03%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 14.57.

All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

GTK    GENTRACK GROUP LIMITED

Software & Services – Overnight Price: $10.68

Canaccord Genuity rates ((GTK)) as Buy (1) –

Canaccord Genuity has made no change to its Buy rating or NZ$14.50 price target for Gentrack Group post the release of interim financials.

Revenue and EBITDA forecasts for FY25FY27 have been revised lower, with EBITDA reduced by -2% to -6% across the forecast period.

The broker notes the result featured a short-term step-down in non-recurring revenue, but strong recurring revenue growth of 17% yoy and ARR of NZ$76m (4% better than forecast) were a positive surprise.

Management re-iterated confidence in its (more than) 15% CAGR mid-term revenue target, with pipeline momentum expected to lift in FY26-FY27, supported by high sales activity in Asia, the Middle East and Europe.

Despite a -9% share price reaction, the analysts believe the downgrade cycle has ended and the longer-term valuation remains attractive

This report was published on May 21, 2025.

Current Price is $10.68. Target price not assessed.
Current consensus price target is $12.83, suggesting upside of 20.2%(ex-dividends)
The company’s fiscal year ends in September.

Forecast for FY25:

Canaccord Genuity forecasts a full year FY25 dividend of 0.00 cents and EPS of 27.08 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 39.44.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 13.3, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 80.3.

Forecast for FY26:

Canaccord Genuity forecasts a full year FY26 dividend of 0.00 cents and EPS of 28.45 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 37.54.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 20.6, implying annual growth of 54.9%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 51.8.

This company reports in NZD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

---

Jarden rates ((GTK)) as Underweight (4) –

Gentrack Group’s 1H25 performance came in below Jarden’s expectations. Revenue growth slowed to 10% year-on-year due to weaker project-related sales in the Utilities division and extended sales cycles.

While FY25 guidance for revenue of at least NZ$230m implies further deceleration in H2, management maintained its target for 15% compound annual growth, highlights the broker. A strong pipeline was cited as support for medium-term momentum.

Reported earnings (EBITDA) margin held at 12%, with the broker observing higher Utilities costs, particularly in product development and sales, offset margin expansion from Veovo, which delivered 24% growth.

Jarden considers current investment levels appropriate given management’s push to expand across Asia and the EMEA region, but flags ongoing near-term margin constraints.

Jarden raises the target price to NZ$8.95 from NZ$7.65 due to forecast earnings changes and a valuation roll forward. Underweight rating.

This report was published on May 20, 2025.

Current Price is $10.68. Target price not assessed.
Current consensus price target is $12.83, suggesting upside of 20.2%(ex-dividends)
The company’s fiscal year ends in September.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 0.00 cents and EPS of 14.32 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 74.60.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 13.3, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 80.3.

Forecast for FY26:

Jarden forecasts a full year FY26 dividend of 0.00 cents and EPS of 23.43 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 45.57.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 20.6, implying annual growth of 54.9%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 51.8.

This company reports in NZD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

---

Moelis rates ((GTK)) as Hold (3) –

Gentrack Group has issued its first formal forecast for 2025, expecting revenue at or above NZ$230m and earnings (EBITDA) margins above 12%. This suggests to Moelis management has improved visibility on near-term earnings.

The analysts observe the base level of revenue guidance is below the broker’s previous estimate of NZ$240m, but notes stronger-than-expected recurring revenue.

Management also reiterated its longer-term ambition for 15% annualised revenue growth.

Moelis highlights that increased spending on R&D and marketing during H1 weighed on margins, though this investment was expensed rather than capitalised, in line with the company’s usual practice.

Veovo (airport software) delivered a strong half, according to Moelis, accounting for 36% of group earnings, with revenue and margin both rising by 24%.

Moelis lowers its target price to $11.59 from $11.85 and maintains a Hold rating.

This report was published on May 19, 2025.

Target price is $11.59 Current Price is $10.68 Difference: $0.91
If GTK meets the Moelis target it will return approximately 9% (excluding dividends, fees and charges).
Current consensus price target is $12.83, suggesting upside of 20.2%(ex-dividends)
The company’s fiscal year ends in September.

Forecast for FY25:

Moelis forecasts a full year FY25 dividend of 0.00 cents and EPS of 16.69 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 64.01.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 13.3, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 80.3.

Forecast for FY26:

Moelis forecasts a full year FY26 dividend of 0.00 cents and EPS of 24.44 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 43.70.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 20.6, implying annual growth of 54.9%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 51.8.

This company reports in NZD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

---

Wilsons rates ((GTK)) as Overweight (1) –

Wilsons notes a softer-than-expected 1H25 result and FY25 guidance for Gentrack Group.

Revenue of NZ$112m and earnings (EBITDA) of NZ$13m missed the broker’s expectations due to weaker non-recurring revenues in Utilities, though Airports delivered a positive surprise with 24% growth and strong margins.

FY25 guidance of revenue above NZ$230m and an earnings margin above 12% implies to the analysts reduced operating earnings. H

The broker anticipates meaningful margin expansion and growth in FY26 as recently won and upcoming contracts scale.

Wilsons lowers its price target to $11.82 from $12.10 and retains an Overweight rating.

This report was published on May 19, 2025.

Target price is $11.82 Current Price is $10.68 Difference: $1.14
If GTK meets the Wilsons target it will return approximately 11% (excluding dividends, fees and charges).
Current consensus price target is $12.83, suggesting upside of 20.2%(ex-dividends)
The company’s fiscal year ends in September.

Forecast for FY25:

Wilsons forecasts a full year FY25 dividend of 0.00 cents and EPS of 12.22 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 87.41.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 13.3, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 80.3.

Forecast for FY26:

Wilsons forecasts a full year FY26 dividend of 0.00 cents and EPS of 20.52 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 52.06.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 20.6, implying annual growth of 54.9%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 51.8.

This company reports in NZD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

LIN    LINDIAN RESOURCES LIMITED

Aluminium, Bauxite & Alumina – Overnight Price: $0.12

Petra Capital rates ((LIN)) as Buy (1) –

Petra Capital highlights the acquisition of Peak Resources ((PEK)) by Shenghe Resources reflects the upside potential for Lindian Resources.

The broker compared Peak’s Ngualla project in Tanzania with the company’s Kangankunde project in Malawi, concluding on all counts the Kangankunde project has better metrics

Buy. Target unchanged at 50c.

This report was published on May 19, 2025.

Target price is $0.50 Current Price is $0.12 Difference: $0.378
If LIN meets the Petra Capital target it will return approximately 310% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.

Forecast for FY25:

Petra Capital forecasts a full year FY25 dividend of 0.00 cents and EPS of minus 0.50 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 24.40.

Forecast for FY26:

Petra Capital forecasts a full year FY26 dividend of 0.00 cents and EPS of minus 0.70 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 17.43.

All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

MM8    MEDALLION METAL LIMITED

Gold & Silver – Overnight Price: $0.25

Petra Capital rates ((MM8)) as Buy (1) –

Petra Capital raises the target price for Medallion Metal to 45c from 43c and maintains a Buy rating following a $27.5m placement to advance the Ravensthorpe Gold Project.

The raise is a strong endorsement of management’s strategy to develop the Kundip Mining Centre, in the broker’s view.

The proceeds will be directed to feasibility studies, drilling, permitting and the potential acquisition of Forrestania assets from IGO Ltd ((IGO)), oberves the analyst.

The broker’s valuation has risen due to the higher post-placement cash balance. Further de-risking milestones and updates on the IGO transaction and project permitting through 2025 are expected.

This report was published on May 20, 2025.

Target price is $0.45 Current Price is $0.25 Difference: $0.2
If MM8 meets the Petra Capital target it will return approximately 80% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.

Forecast for FY25:

Petra Capital forecasts a full year FY25 dividend of 0.00 cents and EPS of minus 0.60 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 41.67.

Forecast for FY26:

Petra Capital forecasts a full year FY26 dividend of 0.00 cents and EPS of minus 1.30 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 19.23.

Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

NHC    NEW HOPE CORPORATION LIMITED

Coal – Overnight Price: $3.70

Goldman Sachs rates ((NHC)) as Sell (5) –

Goldman Sachs has maintained a Sell rating on New Hope Corp, implementing a modest lift in its 12-month price target to $3.00 from $2.90, following a weaker-than-expected Q3 FY25 market update.

FY25 coal sales and production guidance at New Acland were cut by circa -10% due to rail constraints and weather disruptions, while Bengalla remained on track. EBITDA for the quarter fell short of consensus, driven by lower realised prices.

Goldman cut FY25 EBITDA forecasts by -7% and reduced net asset value (NAV) by -2%.

While long-term production remains on track, softer pricing and infrastructure limitations continue to cap upside, with the shares seen trading at a premium, offering a negative total return forecast.

This report was published on May 20, 2025.

Target price is $2.90 Current Price is $3.70 Difference: minus $0.8 (current price is over target).
If NHC meets the Goldman Sachs target it will return approximately minus 22% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $4.15, suggesting upside of 12.2%(ex-dividends)
The company’s fiscal year ends in July.

Forecast for FY25:

Goldman Sachs forecasts a full year FY25 EPS of 46.00 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 8.04.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 53.0, implying annual growth of -5.9%.
Current consensus DPS estimate is 32.8, implying a prospective dividend yield of 8.9%.
Current consensus EPS estimate suggests the PER is 7.0.

Forecast for FY26:

Goldman Sachs forecasts a full year FY26 EPS of 36.00 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 10.28.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 43.3, implying annual growth of -18.3%.
Current consensus DPS estimate is 26.0, implying a prospective dividend yield of 7.0%.
Current consensus EPS estimate suggests the PER is 8.5.

Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

RHC    RAMSAY HEALTH CARE LIMITED

Healthcare services – Overnight Price: $36.08

Goldman Sachs rates ((RHC)) as Neutral (3) –

Ramsay Health Care’s 52.79%-owned European subsidiary Ramsay Sante’s 3Q25 quarter update showed an increase in revenue growth, which Goldman Sachs reckons is a solid outcome.

Growth was achieved despite the headwind from the French government’s revenue guarantee removal. EBITDA margin was flat vs 1H25 but EBITA margins expanded by 70bps on lower operating costs.

The broker upgraded Ramsay Sante’s FY25 EBITA margin to reflect the 3Q improvement and also raised the revenue estimate. Net interest expenses were also lifted.

The result was a lift in the company’s FY25 and FY26 EPS forecasts. Neutral. Target rises to $39.00 from $38.70.

This report was published on May 19, 2025.

Target price is $39.00 Current Price is $36.08 Difference: $2.92
If RHC meets the Goldman Sachs target it will return approximately 8% (excluding dividends, fees and charges).
Current consensus price target is $38.16, suggesting upside of 5.8%(ex-dividends)
The company’s fiscal year ends in June.

Forecast for FY25:

Goldman Sachs forecasts a full year FY25 dividend of 80.00 cents and EPS of 9.00 cents.
At the last closing share price the estimated dividend yield is 2.22%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 400.89.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 121.8, implying annual growth of -68.1%.
Current consensus DPS estimate is 71.4, implying a prospective dividend yield of 2.0%.
Current consensus EPS estimate suggests the PER is 29.6.

Forecast for FY26:

Goldman Sachs forecasts a full year FY26 dividend of 95.00 cents and EPS of 1.48 cents.
At the last closing share price the estimated dividend yield is 2.63%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 2437.84.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 158.9, implying annual growth of 30.5%.
Current consensus DPS estimate is 101.4, implying a prospective dividend yield of 2.8%.
Current consensus EPS estimate suggests the PER is 22.7.

Market Sentiment: 0.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

---

Disclaimer:
The content of this information does in no way reflect the opinions of FNArena, or of its journalists. In fact we don’t have any opinion about the stock market, its value, future direction or individual shares. FNArena solely reports about what the main experts in the market note, believe and comment on. By doing so we believe we provide experienced, intelligent investors with a valuable tool that helps them in making up their own minds, reading market trends and getting a feel for what is happening beneath the surface.

This document is provided for informational purposes only. It does not constitute an offer to sell or a solicitation to buy any security or other financial instrument. FNArena employs very experienced journalists who base their work on information believed to be reliable and accurate, though no guarantee is given that the daily report is accurate or complete. Investors should contact their personal adviser before making any investment decision.

Decisions about inclusions in this Report are made independently of the providers of stock market research and at full discretion of the team of journalists responsible for content at FNArena. Inclusion does not equal endorsement, in any way, shape or form. This Report is provided for informational purposes only.

Click to view our Glossary of Financial Terms